Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2003
10/09/2003WO2003082209A2 Cochleates made with purified soy phosphatidylserine
10/09/2003WO2003082203A2 Elastin prevents occlusion of body vessels by vascular smooth muscle cells
10/09/2003WO2003082200A2 Potent oncolytic herpes simplex virus for cancer therapy
10/09/2003WO2003082197A2 Immunosuppressant compounds, methods and uses related thereto
10/09/2003WO2003082196A2 Combination therapy using trefoil peptides
10/09/2003WO2003082195A2 Protamine-adenoviral vector complexes and methods of use
10/09/2003WO2003082184A2 Truncated lysostaphin molecule with enhanced staphylolytic activity
10/09/2003WO2003082148A1 Enzyme disruption of bacterial biofilms
10/09/2003WO2003082081A2 Use of rom production and release inhibitors to treat and prevent intraocular damage
10/09/2003WO2003082019A2 Peptides with anti-hypertensive properties
10/09/2003WO2003059376A8 The use of il6r/il6 chimera in nerve cell regeneration
10/09/2003WO2003057731A3 Human pheromone receptors
10/09/2003WO2003052132A3 Linear and hairpin oligonucleotide analogues comprising intercalator pseudonucleotides
10/09/2003WO2003052068A3 Mbcats as modifiers of the beta-catenin pathway and methods of use
10/09/2003WO2003048315A3 Antisense modulation of mdm2 expression
10/09/2003WO2003045466A3 Catheter composition and uses thereof
10/09/2003WO2003040686A3 Dosing and administration of therapeutic micro-organs in living subjects and devices and methods for same
10/09/2003WO2003035686A3 Compositions of fsh with high sialylation degree and their use for the preparation of medicaments
10/09/2003WO2003035048A3 Methods for the treatment of osteoarthritis and compositions thereof
10/09/2003WO2003030927A3 Use of thymulin-like peptides for making pain-relieving medicines
10/09/2003WO2003028626A3 Glucagon-like peptides (glp-1) and treatment of respiratory distress
10/09/2003WO2003028621A3 Proteinase inhibitors for treating and diagnosing neurodegenerative diseases
10/09/2003WO2003024389A3 T. reesei phytase enyzmes, polynucleides encoding the enzymes, vectors and host cells thereof, and methods of using
10/09/2003WO2003022880A3 Synthetic hcv envelope proteins and their use for vaccination
10/09/2003WO2003020297A3 Method of improving wound healing
10/09/2003WO2003017922A3 Use of substances with oxytocin activity for the preparation of a pharmaceutical composition against inflammation
10/09/2003WO2003016528A3 Oligonucleotide compositions and their use to induce apoptosis
10/09/2003WO2003016341A3 Regulation of iron uptake
10/09/2003WO2003013604A3 Migenix agonists and antagonists for use in the treatment of metabolic disorders
10/09/2003WO2003013534A3 Methods for the treatment of cancer with irinotecan based on cyp3a5
10/09/2003WO2003013533A3 Methods for improved treatment of cancer with irinotecan based on mrp1
10/09/2003WO2003012133A3 Isp-1 and ctb-1 genes and uses thereof
10/09/2003WO2003007889A3 Therapeutic agents comprising pro-apoptotic proteins
10/09/2003WO2003006893A3 Methods of inhibiting amyloid toxicity
10/09/2003WO2003006481A3 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
10/09/2003WO2003001880A3 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
10/09/2003WO2003000878A3 Use of fkbp chaperones as expression tool
10/09/2003WO2003000865A3 Human secreted proteins
10/09/2003WO2002102828A3 Chimeric flavivirus vectors
10/09/2003WO2002092004A3 Use of hmg fragment as anti-inflammatory agents
10/09/2003WO2002087503A3 Compositions and methods for treating colorectal polyps and cancer
10/09/2003WO2002083929A3 System and method for quantitating transcription factors
10/09/2003WO2002077017A3 Medical uses of intercellular communication facilitating compounds
10/09/2003WO2002076386A3 Method of inducing proliferation of retinal stem cells
10/09/2003WO2002074250A3 Methods and reagents for decreasing clinical reaction to allergy
10/09/2003WO2002071062A3 Diagnosis and treatment of inflammation and hyperactive immune conditions
10/09/2003WO2002070701A3 Novel human gnrh receptor
10/09/2003WO2002069947A3 Antisense oligonucleotides and trichostatin analogue histone deacetylase-4 inhibitors against cancer
10/09/2003WO2002069905A3 Co-administration of melanocortin receptor agonist and phosphodiesterase inhibitor for treatment of cyclic-amp associated disorders
10/09/2003WO2002058687A3 Inhibition of erk to reduce or prevent tolerance to and dependence on opioid analgesics
10/09/2003WO2002057484A3 Method and test system for identifying substances which protect nerve cells
10/09/2003WO2002056905A3 Molecular antigen array
10/09/2003WO2002055063A3 Fumaric acid amides
10/09/2003WO2002053743A3 Mammalian tribbles signaling pathways and methods and reagents related thereto
10/09/2003WO2002046218A3 Treatment of disease by inducing cell apoptosis
10/09/2003WO2002043759A3 Method and composition for modulating bone growth
10/09/2003WO2002040676A3 Mutant allergens
10/09/2003WO2002038797A3 Modulators of bruton's tyrosine kinase, their identification and use
10/09/2003WO2002034791A3 Methods of purification and recovery of interferon-beta
10/09/2003WO2002034284A3 Methods of therapy for hiv infection
10/09/2003WO2002033099A3 Human kinases
10/09/2003WO2002032449A3 Method for treating ischemic events affecting the central nervous system
10/09/2003WO2002031160A3 Regulation of human phospholipase a2-like enzyme
10/09/2003WO2002029072A3 Targetting molecules for adenoviral vectors
10/09/2003WO2002026245A3 Use of serp-1 in combination with an immunosuppressant for influencing inflammatory and immune reactions
10/09/2003WO2002020563A3 RECEPTOR IN THE EDb FIBRONECTIN DOMAIN
10/09/2003WO2002017953A3 Thrombomodulin analogs for use in recovery of signal cord injury
10/09/2003WO2002016612A3 Genes and proteins, and their uses
10/09/2003WO2002016434A9 T CELL RECEPTOR Vβ-Dβ-Jβ SEQUENCE AND METHODS FOR ITS DETECTION
10/09/2003WO2002012290A3 Sid polypeptides binding to pathogenic strain of the hepatitis c virus
10/09/2003WO2002006313A3 Regulation of human glutamate receptor delta-1 subunit
10/09/2003US20030192066 DNA molecule containing an adenoviral inverted terminal repeat (ITR), a packaging signal, a transcriptional control region, effector or reporter gene, generating an infectious, replication-defective genetic engineered adenoviral vector
10/09/2003US20030191319 Alpha-and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
10/09/2003US20030191305 Reacting a 16-sulphonyloxy substituted sterptogramin derivative with alkali metal cyanide, and reducing the compound obtained from the solution
10/09/2003US20030191300 Antisense modulation of bcl-x expression
10/09/2003US20030191291 Synthetic erythropoiesis stimulating proteins
10/09/2003US20030191290 Antibody that binds to the protein; given amino acid sequence
10/09/2003US20030191289 Antibody that binds to the protein; given amino acid sequence
10/09/2003US20030191288 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030191287 Antibody that binds to the protein; given amino acid sequence
10/09/2003US20030191284 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030191283 Nsp molecules
10/09/2003US20030191282 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030191281 Of given amino acid sequence; culturing host cells transformed with vector
10/09/2003US20030191278 Of given amino acid sequence; use as thrombolytic drugs and vasodilators
10/09/2003US20030191193 Bone disorders
10/09/2003US20030191139 Anticoagulant for mammals
10/09/2003US20030191120 Antiparkinsonism drugs
10/09/2003US20030191114 Binding to ligand; induce signals
10/09/2003US20030191109 Beta-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins
10/09/2003US20030191094 Osteoporosis; dihydroxyvitamin D3; suppress gene expression of transcription factors
10/09/2003US20030191084 High affinity nucleic acid ligands of complement system proteins
10/09/2003US20030191080 Cardiovascular disorders; hypotensive agents
10/09/2003US20030191077 Method and reagent for the treatment of asthma and allergic conditions
10/09/2003US20030191072 Gene therapy for proliferative vitreoretinopathy
10/09/2003US20030191068 Salts of the CGRP antagonist BIBN4096 and inhalable powdered medicaments containing them
10/09/2003US20030191067 Hepatitis C inhibitor tri-peptides
10/09/2003US20030191066 Side effect reduction; anticancer agents
10/09/2003US20030191065 Insulin-like growth factor; genetic engineering; central nervous system disorders
10/09/2003US20030191063 Peptide selection method
1 ... 1754 1755 1756 1757 1758 1759 1760 1761 1762 1763 1764 1765 1766 1767 1768 1769 1770 1771 1772 1773 1774 ... 3163